Literature DB >> 19232420

Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Lee-Wen Chen1, Vineetha Raghavan, Pey-Jium Chang, Duane Shedd, Lee Heston, Henri-Jacques Delecluse, George Miller.   

Abstract

The Rta (R transactivator) protein plays an essential role in the Epstein-Barr viral (EBV) lytic cascade. Rta activates viral gene expression by several mechanisms including direct and indirect binding to target viral promoters, synergy with EBV ZEBRA protein, and stimulation of cellular signaling pathways. We previously found that Rta proteins with C-terminal truncations of 30 aa were markedly enhanced in their capacity to bind DNA (Chen, L.W., Chang, P.J., Delecluse, H.J., and Miller, G., (2005). Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus. J. Virol. 79(15), 9635-9650.). Here we show that two phenylalanines (F600 and F605) in the C-terminus of Rta play a crucial role in mediating this DNA binding inhibitory function. Amino acids 555 to 605 of Rta constitute a functional DNA binding inhibitory sequence (DBIS) that markedly decreased DNA binding when transferred to a minimal DNA binding domain of Rta (aa 1-350). Alanine substitution mutants, F600A/F605A, abolished activity of the DBIS. F600 and F605 are located in the transcriptional activation domain of Rta. Alanine substitutions, F600A/F605A, decreased transcriptional activation by Rta protein, whereas aromatic substitutions, such as F600Y/F605Y or F600W/F605W, partially restored transcriptional activation. Full-length Rta protein with F600A/F605A mutations were enhanced in DNA binding compared to wild-type, whereas Rta proteins with F600Y/F605Y or F600W/F605W substitutions were, like wild-type Rta, relatively poor DNA binders. GAL4 (1-147)/Rta (416-605) fusion proteins with F600A/F605A mutations were diminished in transcriptional activation, relative to GAL4/Rta chimeras without such mutations. The results suggest that, in the context of a larger DBIS, F600 and F605 play a role in the reciprocal regulation of DNA binding and transcriptional activation by Rta. Regulation of DNA binding by Rta is likely to be important in controlling its different modes of action.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232420      PMCID: PMC4817495          DOI: 10.1016/j.virol.2009.01.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  78 in total

1.  Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Critical structural elements of the VP16 transcriptional activation domain.

Authors:  W D Cress; S J Triezenberg
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

3.  The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases.

Authors:  A Whitehouse; I M Carr; J C Griffiths; D M Meredith
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.

Authors:  C Rooney; N Taylor; J Countryman; H Jenson; J Kolman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.

Authors:  J Jayaraman; C Prives
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

6.  A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.

Authors:  Ruth J Lin; Mark S Blumenkranz; Jonathan Binkley; Kathy Wu; Douglas Vollrath
Journal:  Am J Ophthalmol       Date:  2006-09-20       Impact factor: 5.258

7.  The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.

Authors:  J J Swenson; A E Mauser; W K Kaufmann; S C Kenney
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.

Authors:  G Decaussin; V Leclerc; T Ooka
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Two distinct domains in the yeast transcription factor IID and evidence for a TATA box-induced conformational change.

Authors:  P M Lieberman; M C Schmidt; C C Kao; A J Berk
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

10.  Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein.

Authors:  Pey-Jium Chang; George Miller
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more
  3 in total

1.  Essential role of Rta in lytic DNA replication of Epstein-Barr virus.

Authors:  Ayman El-Guindy; Maryam Ghiassi-Nejad; Sean Golden; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

2.  Genome-wide analysis of Epstein-Barr virus Rta DNA binding.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Daniel Portal; Yong Lu; Eric Johannsen
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Regulation of autophagic activation by Rta of Epstein-Barr virus via the extracellular signal-regulated kinase pathway.

Authors:  Chien-Hui Hung; Lee-Wen Chen; Wen-Hung Wang; Pey-Jium Chang; Ya-Fang Chiu; Chen-Chia Hung; Ying-Ju Lin; Jieh-Yuan Liou; Wan-Ju Tsai; Chia-Ling Hung; Shih-Tung Liu
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.